AUD 29.88
(-3.18%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 187.51 Million | 141.16 Million | 130.55 Million | 85.29 Million | 80 Million | 46.22 Million |
Net Income | 82.41 Million | 68.16 Million | 58.38 Million | 24.82 Million | 11.22 Million | 37.04 Million |
Depreciation & Amortization | 93.12 Million | 74.22 Million | 59.77 Million | 54.13 Million | 50.44 Million | 9.83 Million |
Deferred income taxes | - | -194.15 Million | -4.73 Million | -3.24 Million | 2.9 Million | -1.83 Million |
Stock-based compensation | - | 25.29 Million | 13.3 Million | 666 Thousand | -577 Thousand | 586 Thousand |
Change in working capital | 6.64 Million | -30.04 Million | 2.32 Million | 305 Thousand | 2.01 Million | -10.35 Million |
Other non-cash items | 191.51 Million | 197.68 Million | 1.5 Million | 8.6 Million | 13.99 Million | 10.95 Million |
Investing Cash Flow | -23.26 Million | -60.72 Million | -34.6 Million | 2.26 Million | -25.56 Million | -24.13 Million |
Investments in PPE | -38.6 Million | -76.86 Million | -37.37 Million | -15.33 Million | -27.16 Million | -23.35 Million |
Acquisitions | - | - | -153 Thousand | 16.21 Million | - | 55 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 15.19 Million | 16.14 Million | 2.92 Million | 1.37 Million | 1.59 Million | -831 Thousand |
Financing Cash Flow | -165.15 Million | -83.61 Million | -97.46 Million | -73.08 Million | -43.66 Million | -32.51 Million |
Debt repayment | -11 Million | -55 Million | -10 Million | -30.84 Million | -31.88 Million | - |
Dividends payments | -88.85 Million | -80.87 Million | -59.1 Million | -37.61 Million | -15.86 Million | -33.78 Million |
Common Stock Repurchased | - | -55.26 Million | - | - | 27.8 Million | - |
Common Stock Issuance | 715 Thousand | 260 Thousand | - | - | 4.08 Million | 1.26 Million |
Other Financing Activities | -66.02 Million | 107.26 Million | -28.36 Million | -4.62 Million | -27.8 Million | 1.26 Million |
Accounts receivables | -14.42 Million | -2.06 Million | -2.06 Million | 1.9 Million | -463 Thousand | -2.53 Million |
Accounts payables | 23.01 Million | -8.45 Million | 10.55 Million | 8.5 Million | -1.42 Million | 11.91 Million |
Inventory | -8.52 Million | -9.88 Million | -16 Million | -12.49 Million | 1.05 Million | -7.82 Million |
Other working capital | 6.57 Million | -9.64 Million | 9.83 Million | 2.39 Million | 2.84 Million | -11.91 Million |
Cash at beginning of period | 31.65 Million | 34.15 Million | 35.55 Million | 20.43 Million | 19.18 Million | 21.05 Million |
Cash at end of period | 30.52 Million | 31.65 Million | 34.15 Million | 35.55 Million | 20.43 Million | 11.19 Million |
Capital Expenditure | -38.6 Million | -76.86 Million | -37.37 Million | -15.33 Million | -27.16 Million | -23.35 Million |
Effect of forex changes on cash | -220 Thousand | 665 Thousand | 115 Thousand | 642 Thousand | -1.53 Million | 558 Thousand |
Net cash flow / Change in cash | -1.13 Million | -2.5 Million | -1.39 Million | 15.11 Million | 1.25 Million | -9.86 Million |
Free Cash Flow | 148.9 Million | 64.29 Million | 93.18 Million | 69.95 Million | 52.83 Million | 22.86 Million |
Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 28.93 Million | 82.41 Million | 53.47 Million | 20.44 Million | 68.16 Million | 47.72 Million |
Depreciation & Amortization | 48.04 Million | 93.12 Million | 45.08 Million | 40.45 Million | 74.22 Million | 33.76 Million |
Deferred income taxes | - | - | - | -93.67 Million | -194.15 Million | - |
Stock-based compensation | - | - | - | 25.29 Million | 25.29 Million | - |
Change in working capital | - | 6.64 Million | - | -12.19 Million | -30.04 Million | - |
Other non-cash items | 79.31 Million | 191.51 Million | 118.9 Million | 63.09 Million | 197.68 Million | 84.12 Million |
Investing Cash Flow | -8.96 Million | -23.26 Million | -14.3 Million | -28.82 Million | -60.72 Million | -31.89 Million |
Investments in PPE | -15.06 Million | -38.6 Million | -23.53 Million | -39.98 Million | -76.86 Million | -36.88 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 6.1 Million | 15.33 Million | 9.23 Million | 11.15 Million | 16.14 Million | 4.99 Million |
Financing Cash Flow | -79.64 Million | -165.15 Million | -85.51 Million | -32.9 Million | -83.61 Million | -50.7 Million |
Debt repayment | -11 Million | -11 Million | -22 Million | -39 Million | -55 Million | -16 Million |
Dividends payments | -54.84 Million | -88.85 Million | -34 Million | -40.97 Million | -80.87 Million | -39.89 Million |
Common Stock Repurchased | - | - | 21.28 Million | - | -55.26 Million | -16.26 Million |
Common Stock Issuance | - | 715 Thousand | 715 Thousand | - | 260 Thousand | 260 Thousand |
Other Financing Activities | -35.79 Million | - | -21.28 Million | 8.06 Million | 107.26 Million | 16.26 Million |
Accounts receivables | - | -14.42 Million | - | -2.65 Million | -2.06 Million | - |
Accounts payables | - | 23.01 Million | - | - | -8.45 Million | - |
Inventory | - | -8.52 Million | - | -9.88 Million | -9.88 Million | - |
Other working capital | - | 6.57 Million | - | 349 Thousand | -9.64 Million | - |
Cash at beginning of period | 58.51 Million | 31.65 Million | 31.65 Million | 50.03 Million | 34.15 Million | 34.15 Million |
Cash at end of period | 20.88 Million | 20.88 Million | 58.51 Million | 31.65 Million | 31.65 Million | 50.03 Million |
Capital Expenditure | -15.06 Million | -38.6 Million | -23.53 Million | -39.98 Million | -76.86 Million | -36.88 Million |
Effect of forex changes on cash | - | - | -622 Thousand | 272 Thousand | 665 Thousand | 393 Thousand |
Net cash flow / Change in cash | -37.63 Million | -10.77 Million | 26.86 Million | -18.38 Million | -2.5 Million | 15.88 Million |
Free Cash Flow | 45.14 Million | 148.9 Million | 103.76 Million | 3.09 Million | 64.29 Million | 61.2 Million |
CVS
8456
PYCT
300833
RVNC
002015